Alain Horvais, a Partner specializing in Healthtech at Kurma Partners. See sector focus and contact routes.
Alain Horvais, a Partner specializing in Healthtech at Kurma Partners, previously served as a 10-year Research Director at Bio-Rad Paris and a Companion Diagnostics Director at Astra Zeneca in the UK. His investment focus centers on biotechnology, lifesciences, drug development, and specifically the Kurma Diagnostics fund, which targets IVD diagnostics and biomarkers. While Kurma Partners generally invests in early-stage healthcare and biotechnology companies across Europe, Horvais’s specific check sizes and lead/follow behavior are not publicly disclosed. His notable portfolio involvement includes serving as a Board Member at FeetMe and an Advisor at DeepUll. Horvais distinguishes himself as a specialist in IVD diagnostics and biomarkers who has publicly analyzed the industrial risks and limits of developing complex biomarkers. He holds a Doctorate in Molecular Biology and a Master’s in Innovation Management, grounding his venture activities in deep scientific expertise.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Paris.
Investors like Alain Horvais · Full investor directory · Investor access · Company funding database